SEC filing record
Primary Source · SEC.gov

CEREHEALTH CORP

2021 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Raised

$3M

Investors

47

Min Invest

$25,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

CEREHEALTH CORP is a Delaware corporation that first filed a Form D on January 13, 2012 and most recently amended it on August 10, 2023 in the Other Health Care industry group. The offering claims Rule 506(b). CEREHEALTH CORP reported $2,881,532 sold from 47 investors of a $5,250,000 total offering as of the Form D filed August 10, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $25,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 991 Southpark Drive, Suite 200, Littleton, CO 80120.

Critical Disclosures

What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.

Reporting lapsed · Form D · last filing August 10, 2023

Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.

Timeline
Each line is a fact as filed. The history behind it, the same event across other issuers, and an alert on the next one:Open in the terminal Watch this issuer

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001440747
Entity NameCEREHEALTH CORP
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address991 Southpark Drive, Suite 200, Littleton, CO 80120
Phone(720) 506-4071
Former NamesCERESCAN CORP (until November 19, 2013)
Industry / Fund TypeOther Health Care
Securities Type—
First Sale DateAugust 13, 2021
Filing DateAugust 10, 2023
Accession Number0001440747-23-000001
Total Offering Amount$5,250,000
Total Amount Sold$2,881,532
Amount Remaining$2,368,468
Total Investors47
Non-Accredited InvestorsNone
Minimum Investment$25,000
Offering DurationIntended to last more than one year
Revenue RangeDecline to Disclose
State (Issuer Address)CO
Amendment Count7 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

0

none on file

Critical / warning

0 / 0

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

4

closed, lapsed, dark

Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 4 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Shane Quint

Executive Officer · Littleton, CO

President and CTO

John Q. Adams, Sr.

Director · Littleton, CO

Robert Q. Connelly

Director · Littleton, CO

T. Richard Fort

Director · Littleton, CO

Peter Barton Hutt

Director · Littleton, CO

Kelley Barton John

Executive Officer, Director · Littleton, CO

Heather Barton Callender-Potters

Director · Littleton, CO

Mark Richard Lindsay

Director · Littleton, CO

Wendy Richard Turman

Executive Officer · Littleton, CO

Chief Financial Officer

Brett Richard Green

Executive Officer · Littleton, CO

Questions About CEREHEALTH CORP

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is CEREHEALTH CORP?

CEREHEALTH CORP is a Delaware corporation that filed a Form D with the SEC on August 10, 2023 in the Other Health Care industry group. The filing claims Rule 506(b).

Is CEREHEALTH CORP legit?

AltStreet does not rate legitimacy; it reports the public record. CEREHEALTH CORP filed a Form D with the SEC on August 10, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $2,881,532 sold to 47 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is CEREHEALTH CORP registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that CEREHEALTH CORP claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has CEREHEALTH CORP raised?

CEREHEALTH CORP reported $2,881,532 sold from 47 investors of a $5,250,000 total offering as of the Form D filed August 10, 2023.

Who can invest in CEREHEALTH CORP?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $25,000.

What is the minimum investment in CEREHEALTH CORP?

The Form D lists $25,000 as the minimum investment accepted from any outside investor as of August 10, 2023. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling CEREHEALTH CORP and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.

Who is behind CEREHEALTH CORP?

The Form D lists 10 related persons: Shane Quint, executive officer (President and CTO); John Q. Adams, Sr., director; Robert Q. Connelly, director; T. Richard Fort, director; Peter Barton Hutt, director; Kelley Barton John, executive officer, director; Heather Barton Callender-Potters, director; Mark Richard Lindsay, director, and 2 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is CEREHEALTH CORP located?

The issuer's address on its SEC filings is 991 Southpark Drive, Suite 200, Littleton, CO 80120. Its phone number of record is 720-506-4071. It is organized under the laws of Delaware.

How long is the CEREHEALTH CORP offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 2 amendments are on record for this CIK.

What is CEREHEALTH CORP's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.